Clover logo

CLV - Clover Share Price

A$1.19 -0.0  -2.5%

Last Trade - 5:10am

Consumer Defensives
Small Cap
Market Cap £113.1m
Enterprise Value £116.1m
Revenue £49.2m
Position in Universe 595th / 1847
Unlock CLV Revenue
Relative Strength (%)
1m -20.7%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -56.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Jul 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
29.9 42.9 47.9 63.0 76.7 88.3 78.7 107 +24.2%
-89.6 +2,097 +64.4 +107.4 +32.8 +23.5 -26.6 +50.9
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 July 2020, CloverCorporation Limited revenues increased 15% to A$88.3M. Netincome increased 24% to A$12.5M. Revenues reflectAustralia/ New Zealand segment increase of 19% to A$46M,Europe segment increase of 94% to A$11.5M. Dividend pershare increased from A$0.02 to A$0.03. Basic Earnings perShare excluding Extraordinary Items increased from A$0.06to A$0.08.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CLV Revenue Unlock CLV Revenue

Net Income

CLV Net Income Unlock CLV Revenue

Normalised EPS

CLV Normalised EPS Unlock CLV Revenue

PE Ratio Range

CLV PE Ratio Range Unlock CLV Revenue

Dividend Yield Range

CLV Dividend Yield Range Unlock CLV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CLV EPS Forecasts Unlock CLV Revenue
Profile Summary

Clover Corporation Limited is an Australia-based company, which is engaged in the refining and sale of natural oil. The Company is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. It focuses on developing nutrients for use in foods or as nutritional supplements. The Company provides lipid-based ingredients for the food industry. It focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. The Company offers an encapsulated oil and a food grade high docosahexaenoic acid (DHA) oil. It has a technology license for the encapsulation of marine and algal oils. The Company has a manufacturing plant for tuna oils and related products in Altona, Victoria. Its geographical segments include Australia/New Zealand, Asia, Europe and America.

Last Annual July 31st, 2020
Last Interim July 31st, 2020
Incorporated September 29, 1988
Public Since November 30, 1999
No. of Shareholders: 5,976
No. of Employees: 49
Sector Consumer Defensives
Industry Food & Tobacco
Index S&P/ASX All Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 166,310,104
Free Float (0.0%)
Eligible for
CLV Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CLV
Upcoming Events for CLV
Frequently Asked Questions for Clover
What is the Clover share price?

As of 5:10am, shares in Clover are trading at A$1.19, giving the company a market capitalisation of £113.1m. This share price information is delayed by 15 minutes.

How has the Clover share price performed this year?

Shares in Clover are currently trading at A$1.19 and the price has moved by -49.17% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Clover price has moved by -53.54% over the past year.

What are the analyst and broker recommendations for Clover?

Of the analysts with advisory recommendations for Clover, there are there are currently 1 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Clover is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Clover next release its financial results?

Clover is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-07-31
What is the Clover dividend yield?

The Clover dividend yield is 2.05% based on the trailing twelve month period.

Does Clover pay a dividend?

Last year, Clover paid a total dividend of 0.03, and it currently has a trailing dividend yield of 2.05%. Looking ahead, Clover has not announced an ex-dividend date yet.

When does Clover next pay dividends?

Clover has yet to annouce their ex-dividend date. The historic dividend yield on Clover shares is currently 2.05%.

How do I buy Clover shares?

To buy shares in Clover you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Clover?

Shares in Clover are currently trading at A$1.19, giving the company a market capitalisation of £113.1m.

Where are Clover shares listed? Where are Clover shares listed?

Here are the trading details for Clover:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: CLV
What kind of share is Clover?

Based on an overall assessment of its quality, value and momentum, Clover is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Clover share price forecast 2021?

Shares in Clover are currently priced at A$1.19. At that level they are trading at 87.3% discount to the analyst consensus target price of 0.00.

Analysts covering Clover currently have a consensus Earnings Per Share (EPS) forecast of 0.055 for the next financial year.

How can I tell whether the Clover share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clover. Over the past six months, the relative strength of its shares against the market has been -53.75%. At the current price of A$1.19, shares in Clover are trading at -36.55% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Clover PE Ratio?

The Clover PE ratio based on its reported earnings over the past 12 months is 16.28. The shares are currently trading at A$1.19.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Clover?

Clover's management team is headed by:

D. Pierotti - OTH
C. Patch - OTH
S. Phoothong - OTH
Graeme Billings - NID
G Elliott - OTH
Peter Davey - CEO
Rupert Harrington - NEC
Paul Sherman - CFO
Ian Glasson - DRC
Who are the major shareholders of Clover?

Here are the top five shareholders of Clover based on the size of their shareholding:

Washington H Soul Pattinson and Company Ltd Investment Advisor
Percentage owned: 20.27% (33.7m shares)
Perpetual Investment Management Limited Investment Advisor/Hedge Fund
Percentage owned: 7.64% (12.7m shares)
Evelin Investments Pty. Ltd. Corporation
Percentage owned: 4.54% (7.55m shares)
Pengana Emerging Companies Fund Mutual Fund
Percentage owned: 1.89% (3.14m shares)
Incani & Papadopoulos Super Pty. Ltd. Corporation
Percentage owned: 1.21% (2.01m shares)
Similar to CLV
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.